--- title: "Pre-market hot trades in US stocks: Artelo Biosciences pre-market down 17.32%; CollPlant Biotech pre-market up 9.54%" type: "News" locale: "en" url: "https://longbridge.com/en/news/280590737.md" description: "Artelo Biosciences pre-market down 17.32%; CollPlant Biotech pre-market up 9.54%; EpicQuest Edu pre-market up 164.09%; Fitness Champs pre-market up 109.36%; Newbridge Acquisition pre-market up 55.77%" datetime: "2026-03-26T08:22:39.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280590737.md) - [en](https://longbridge.com/en/news/280590737.md) - [zh-HK](https://longbridge.com/zh-HK/news/280590737.md) --- # Pre-market hot trades in US stocks: Artelo Biosciences pre-market down 17.32%; CollPlant Biotech pre-market up 9.54% **Pre-market Hot Trades in US Stocks** Artelo Biosciences is down 17.32% in pre-market trading. Based on recent key news: 1. On March 25, Artelo Biosciences announced via GlobeNewswire that it emphasized three clinical projects for its core molecular development, showcasing the company's long-term growth potential in the biopharmaceutical field. However, the market reacted poorly to its capital efficiency and sustainability strategies, leading to a decline in stock price. 2. On March 24, Artelo Biosciences filed relevant documents with the SEC's EDGAR system. Although the company highlighted its strategic positioning, investor confidence in its future growth was insufficient, further exacerbating downward pressure on the stock price. The biopharmaceutical industry has been highly volatile recently, and investors should exercise caution. CollPlant Biotech is up 9.54% in pre-market trading. Based on recent news: 1. On March 24, CollPlant Biotechnologies received a notification from Nasdaq regarding minimum bid requirements. The company's stock closed below $1 for 30 consecutive trading days, failing to meet Nasdaq listing rule 5550(a)(2). The company has been given 180 days, until September 21, 2026, to regain compliance. This news has attracted market attention, leading to stock price fluctuations. 2. On March 24, CollPlant Biotechnologies announced its latest advancements in regenerative and aesthetic medicine. The company is developing breakthrough technologies and products using its unique recombinant human collagen platform. This announcement has bolstered market confidence in the company's future development, driving the stock price up. 3. On March 24, CollPlant Biotechnologies disseminated the above information via PR Newswire, further expanding the reach of the news and increasing market attention on the stock. The regenerative medicine and aesthetic fields have broad prospects, and investors should pay attention to market volatility risks. **Top Gainers in Pre-market US Stocks** EpicQuest Edu is up 164% in pre-market trading. Based on recent key news: 1. On March 25, EpicQuest Education Group announced that director Cui Xiaojun holds stock options for 15,467 shares of common stock, with exercise prices ranging from $7.17 to $18.56. This news may trigger market expectations for a rise in the company's future stock price, leading to a significant increase in stock price. Source: EDGAR system disclosure. 2. On March 23, EpicQuest Education Group released relevant content emphasizing the company's responsibility for information. This may enhance investor confidence in the company's transparency, further driving the stock price up. Source: EDGAR system disclosure. The education sector has been active recently, with significant capital inflows Fitness Champs pre-market rose 109.36%. Based on recent key news: 3. On March 25, Fitness Champs Holdings announced plans to issue stocks and warrants, leading to stock price fluctuations. This news attracted market attention, and although the stock price surged in pre-market trading, it retreated during the trading session. 4. On March 24, the company received support for a flexible share consolidation plan at a special shareholders' meeting. This move is seen as part of the company's capital structure adjustment and may have a long-term impact on the stock price. 5. On March 23, the company released relevant information through the EDGAR system, emphasizing its responsibility for the information. This transparency has increased investor trust in the company, which may have a positive impact on the stock price. The market's reaction to the new stock issuance has been mixed, leading to increased volatility. Newbridge Acquisition, pre-market rose 55.77%, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation ### Related Stocks - [ARTL.US](https://longbridge.com/en/quote/ARTL.US.md) - [CLGN.US](https://longbridge.com/en/quote/CLGN.US.md) ## Related News & Research - [Artelo Biosciences Q1 net loss widens, R&D expenses fall](https://longbridge.com/en/news/286462732.md) - [Sharma says China remains 'incomplete superpower' despite gains](https://longbridge.com/en/news/286843518.md) - [TGT Stock Alert: What to Know as Target Taps Former Walmart Exec](https://longbridge.com/en/news/286957668.md) - [Should you invest $1,000 in AGNC Investment right now?](https://longbridge.com/en/news/286802595.md) - [Explained: What are bond yields and why markets watch them closely?](https://longbridge.com/en/news/287168006.md)